Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis ; volume:18 ; number:1 ; day:19 ; month:7 ; year:2017 ; pages:1-10 ; date:12.2017
BMC nephrology ; 18, Heft 1 (19.7.2017), 1-10, 12.2017
- Keyword
-
Urologie
Urogenitalkrankheit
Harnwegskrankheit
- Creator
-
Du, Bing
- Contributor
-
Jia, Ye
Zhou, Wenhua
Min, Xu
Miao, Lining
Cui, Wenpeng
SpringerLink (Online service)
- DOI
-
10.1186/s12882-017-0647-x
- URN
-
urn:nbn:de:1111-20170823480
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Du, Bing
- Jia, Ye
- Zhou, Wenhua
- Min, Xu
- Miao, Lining
- Cui, Wenpeng
- SpringerLink (Online service)
Other Objects (12)
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil
Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice
Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review
A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil